产碳青霉烯酶肠杆菌目细菌感染临床特征、耐药性及预后:一项前瞻性单中心研究OA
Clinical characteristics,antimicrobial resistance,and prognosis of carbape-nemase-procucing Enterobacterales infection:a prospective single center study
目的 检测耐碳青霉烯类肠杆菌目细菌(CRE)感染患者分离菌株的碳青霉烯酶类型,分析细菌耐药性、感染患者临床特征,以及影响患者预后的相关因素.方法 前瞻性收集2023-2024年某二级甲等综合医院成人住院患者临床分离的非重复CRE菌株,检测碳青霉烯酶类型,调查患者的临床资料,通过单因素和多因素回归模型分析影响产碳青霉烯酶肠杆菌目细菌(CPE)感染患者临床治疗结局的影响因素.结果 共收集151例CRE感染患者临床资料,检出耐碳青霉烯类肺炎克雷伯菌(CRKP)最多(134株,88.7%).151株CRE均检出碳青霉烯酶,其中单产A类丝氨酸碳青霉烯酶(均为 KPC型)111株(73.5%),单产B-类金属β-内酰胺酶(MBL)32株(21.2%),联产KPC+MBL 8株(5.3%),CRKP以KPC酶为主(82.1%),耐碳青霉烯类大肠埃希菌(CREC)、耐碳青霉烯类阴沟肠杆菌(CRECL)均产 MBL酶.151株CPE菌株对氨苄西林/舒巴坦、哌拉西林/他唑巴坦、头孢哌酮/舒巴坦、替卡西林/克拉维酸的耐药率均达90%以上.单产金属酶 MBL菌株与联合产酶(DCP)菌株对头孢他啶/阿维巴坦耐药率高于单产KPC酶菌株(均P<0.05);单产KPC酶与DCP菌株对氨基糖苷类药物、多西环素与复方磺胺甲口恶唑的耐药率高于单产金属酶 MBL菌株(均P<0.05).三类CPE菌株均对多黏菌素B较敏感,耐药率为0~4.2%;产KPC酶与 MBL酶菌株对替加环素耐药率低(0~4.2%),DCP菌株对替加环素耐药率为100%.27.2%(41例)患者在发生感染后30 d内死亡,多因素回归分析结果表明,医院感染(OR=12.88,95%CI:4.15~39.96)、留置胃管(OR=10.51,95%CI:2.19~50.45)、感染时空腹血糖水平较高(OR=1.24,95%CI:1.08~1.41)均为CPE感染患者感染后30 d死亡的独立危险因素;而感染时血清清蛋白水平较高(OR=0.80,95%CI:0.70~0.90)则为独立保护性因素.结论 二级综合性医院CPE流行率高,耐药形势严峻,尤其KPC型与DCP菌株耐药谱更为广泛.需重视CRE筛查与酶型监测,预防医院感染,同时关注高危人群,改善患者临床预后.
Objective To detect carbapenemase types in strains isolated from patients with carbapenem-resistant Enterobacterales(CRE)infection,analyze bacterial resistance,clinical characteristics of infected patients,and related factors affecting patients'prognosis.Methods Non-repetitive CRE strains isolated from adult inpatients in a secondary first-class general hospital from 2023 to 2024 were collected prospectively.Carbapenemase types were detected,patients'clinical data were investigated,and factors affecting the clinical treatment outcome of patients with carbapenemase-procucing Enterobacterales(CPE)infection were analyzed with univariate and multivariate regression models.Results Clinical data of 151 CRE infected patients were collected,the detection of carbapenem-resistant Klebsiella pneumoniae(CRKP)took the highest proportion(n=134,88.7%).All of the 151 CRE strains contained carbapenemase,including 111 strains(73.5%)containing only class A serine carbapenemase(all KPC type),32 strains(21.2%)containing only class B metallo-β-lactamase(MBL),and 8 strains(5.3%)contai-ning both KPC and MBL(double-carbapenemase-producing,DCP).KPC represented the main form in CRKP(82.1%).Both carbapenem-resistant Escherichia coli(CREC)and carbapenem-resistant Enterobacter cloacae(CRECL)produced MBL.The resistance rates of 151 CPE strains to ampicillin/sulbactam,piperacillin/tazobac-tam,cefoperazone/sulbactam,and ticarcillin/clavulanic acid were all over 90%.The resistance rates to ceftazidime/avibactam in only-MBL-producing strains and DCP strains were higher than those in only-KPC-producing strains(both P<0.05).The resistance rates of only-KPC-producing and DCP strains to aminoglycosides,doxycycline,and compound sulfamethoxazole were higher than those of only-MBL-producing strains(all P<0.05).All three types of CPE strains had good sensitivity to polymyxin B,with a resistance rate of 0-4.2%.The resistance rates of KPC-and MBL-producing strains to tigecycline were low(0-4.2%),while the resistance rate of DCP strains to tigecycline was 100%.27.2%(n=41)of patients died within 30 days after infection.Multivariate regression analysis showed that healthcare-associated infection(HAI)(OR=12.88,95%CI:4.15-39.96),indwelling gastric tube(OR=10.51,95%CI:2.19-50.45),and high abdominal blood glucose level during infection(OR=1.24,95%CI:1.08-1.41)were all independent risk factors for death within 30 days after infection in patients with CPE infection,while high serum albumin level during infection(OR=0.80,95%CI:0.70-0.90)was an inde-pendent protective factor.Conclusion The prevalence of CPE in secondary general hospitals is high,and antimicro-bial resistance is severe,especially in the cases of KPC-producing and DCP strains showing wider spectrum of anti-microbial resistance.Attention should be paid to CRE screening and enzyme type monitoring to prevent HAI.High-risk populations should also be paid attention to improve clinical prognosis.
朱雯;范俊华;梁艺;戴菲菲;翁超;朱仁义
上海市杨浦区市东医院 上海理工大学附属市东医院医院感染管理科,上海 200438上海市疾病预防控制中心传染病防治所,上海 201107上海市杨浦区市东医院 上海理工大学附属市东医院医院感染管理科,上海 200438上海市杨浦区市东医院 上海理工大学附属市东医院医院感染管理科,上海 200438上海市杨浦区市东医院 上海理工大学附属市东医院医院感染管理科,上海 200438上海市疾病预防控制中心传染病防治所,上海 201107
医药卫生
肠杆菌目细菌产碳青霉烯酶肠杆菌目细菌医院感染预后危险因素
Enterobacteralescarbapenemase-producing Enterobacteraleshealthcare-associated infectionprognosisrisk factor
《中国感染控制杂志》 2026 (1)
8-17,10
2023年度杨浦区科学技术委员会 杨浦区卫生健康委员会科研项目公共卫生专项(面上项目)(YPGWM202303)杨浦区卫健系统"好医师"建设工程(2024-2026年度)(240402)上海市杨浦区市东医院院级课题(YJYB04)
评论